Fig. 1From: Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinomaOverall Survival. Median OS: entire cohort - 34.2 (range, 2.0–53.7) months, non-transplanted patients - 23.3 (range, 2.3–34.3) months, transplanted patients - not reachedBack to article page